{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:35:22Z","timestamp":1775298922455,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2018.12.037","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T12:55:30Z","timestamp":1545051330000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation"],"prefix":"10.1016","volume":"164","author":[{"given":"Flavia","family":"Cuviello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faustino","family":"Bisaccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Francesca","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabino Aurelio","family":"Bufo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3841-5389","authenticated-orcid":false,"given":"Barbara","family":"Cosimelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ostuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.12.037_bib1","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"12","author":"Pushpakom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.12.037_bib2","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1021\/jm020815d","article-title":"Cardiovascular characterization of [1,4]thiazino[3,4-c][1,2,4]oxadiazol-1-one derivatives: selective myocardial calcium channel modulators","volume":"45","author":"Budriesi","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib3","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/jm0493414","article-title":"A\u00a0new class of selective myocardial calcium channel modulators 2. Role of the acetal chain in oxadiazol-3-one derivatives","volume":"48","author":"Budriesi","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/ml300436x","article-title":"ABCB1 structural models, molecular docking, and synthesis of new oxadiazolothiazin-3-one inhibitors","volume":"4","author":"Rosano","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.12.037_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10637-009-9340-7","article-title":"Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in\u00a0vitro analysis","volume":"29","author":"Viale","year":"2011","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2018.12.037_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/jm801195k","article-title":"Inhibition of MDR1 activity in\u00a0vitro by a novel class of diltiazem analogues: toward new candidates","volume":"52","author":"Viale","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","article-title":"Multidrug resistance proteins (MRPs) and cancer therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2018.12.037_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fphar.2016.00535","article-title":"The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy","volume":"7","author":"El-Awady","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.037_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12703\/P7-14","article-title":"Structure and mechanism of ABC transporters","volume":"7","author":"Wilkens","year":"2015","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.ejmech.2018.12.037_bib10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2174\/1389450116666150330113506","article-title":"ABC transporter inhibitors in reversing multidrug resistance to chemotherapy","volume":"16","author":"Cui","year":"2015","journal-title":"J.\u00a0Curr. Drug. Targets"},{"key":"10.1016\/j.ejmech.2018.12.037_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejmech.2017.07.062","article-title":"Overcoming ABC transporter-mediated multidrug resistance: the dual role of tyrosine kinase inhibitors as multitargeting agents","volume":"142","author":"Beretta","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bse0500209","article-title":"The controversial role of ABC transporters in clinical oncology","volume":"50","author":"Tamaki","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib13","first-page":"6172","article-title":"Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6)","volume":"62","author":"Belinsky","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.12.037_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-017-0639-8","article-title":"Pseudoxanthoma elasticum","volume":"12","author":"Germain","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejmech.2018.12.037_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2478\/s11658-014-0208-2","article-title":"Dysregulation of gene expression in ABCC6 knockdown HepG2 cells","volume":"19","author":"Miglionico","year":"2014","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2018.12.037_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10863-016-9654-z","article-title":"New insights into the roles of the N-terminal region of the ABCC6 transporter","volume":"48","author":"Miglionico","year":"2016","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2018.12.037_bib17","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.febslet.2015.10.030","article-title":"Membrane insertion and topology of the amino-terminal domain TMD0 of multidrug-resistance associated protein 6 (MRP6)","volume":"589","author":"Cuviello","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2018.12.037_bib18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbrc.2014.07.046","article-title":"Live-cell topology assessment of URG7, MRP6 and SP-C using glycosylatable green fluorescent protein in mammalian cells","volume":"450","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2018.12.037_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10863-011-9372-5","article-title":"The nucleotide-binding domain 2 of the human transporter protein MRP6","volume":"43","author":"Ostuni","year":"2011","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2018.12.037_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4081\/hr.2017.7406","article-title":"Expression of some ATP-binding cassette transporters in acute myeloid leukemia","volume":"9","author":"Salvia","year":"2017","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.ejmech.2018.12.037_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11658-017-0036-2","article-title":"ABCC6 knockdown in HepG2 cells induces a senescent-like cell phenotype","volume":"22","author":"Miglionico","year":"2017","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2018.12.037_bib22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/092986610791306751","article-title":"Biochemical characterization and NMR study of the region E748-A785 of the human protein MRP6\/ABCC6","volume":"17","author":"Ostuni","year":"2010","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejmech.2018.12.037_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2133\/dmpk.DMPK-12-RG-143","article-title":"Evaluation of the inhibitory effects of antihypertensive drugs on human carboxylesterase in\u00a0vitro","volume":"28","author":"Yanjiao","year":"2013","journal-title":"Drug Metab. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.037_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/dmd.113.053512","article-title":"INDICES Consortium, in\u00a0vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors","volume":"42","author":"Thomsen","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2018.12.037_bib25","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1038\/onc.2014.453","article-title":"KATs in cancer: functions and therapies","volume":"34","author":"Farria","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.12.037_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4155\/fmc-2017-0244","article-title":"Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications","volume":"10","author":"Fiorentino","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib27","article-title":"Non-histone targets of KAT2A and KAT2B implicated in cancer biology","author":"Bondy-Chorney","year":"2018","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.12.037_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-05-0135","article-title":"Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity","volume":"4","author":"Stimson","year":"2005","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.12.037_bib29","first-page":"467","article-title":"Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs), Bioorg","volume":"17","author":"Gorsuch","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bmc.2008.12.008","article-title":"Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones","volume":"17","author":"Dekker","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2015.12.010","article-title":"The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory g ene expression and inhibits histone deacetylases","volume":"102","author":"van den Bosch","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.12.037_bib32","doi-asserted-by":"crossref","first-page":"16860","DOI":"10.1074\/jbc.M110918200","article-title":"Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6)","volume":"277","author":"Ilias","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biocel.2008.05.026","article-title":"Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A","volume":"41","author":"Codd","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.12.037_bib34","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1016\/S0021-9258(18)33695-0","article-title":"Inhibition of histone acetylation by N-[2-(S-coenzyme A) acetyl] spermidine amide, a multisubstrate analog","volume":"257","author":"Cullis","year":"1982","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib35","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib36","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.12.037_bib37","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1535-7163.MCT-07-0159","article-title":"Characterization of novel inhibitors of histone acetyltransferases","volume":"6","author":"Eliseeva","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.12.037_bib38","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/oncsis.2014.51","article-title":"Histone acetyltransferase inhibitors block neuroblastoma cell growth in\u00a0vivo","volume":"4","author":"Gajer","year":"2015","journal-title":"Oncogenesis"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:46:39Z","timestamp":1759326399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418310742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":38,"alternative-id":["S0223523418310742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.037","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}